Skip to content

The Effectiveness of Smart Health Management Program for Patients With Chronic Illness

The Effectiveness of Smart Health Management Program With Proactive Overcoming for Patients With Chronic Illness: Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03294044
Enrollment
106
Registered
2017-09-26
Start date
2017-10-27
Completion date
2018-07-31
Last updated
2018-10-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Dyslipidemias, Hypertension

Keywords

Self-Management IT Program

Brief summary

This study verifies efficacy of Smart Health Management Program developed for patients with chronic illness. The aim of the study is to observe the changes in clinical indicators, quality of life and health related behaviors when providing self-management programs with ICT for chronic disease patients.

Detailed description

This study is to demonstrate that chronic disease patients (hypertension, diabetes and dyslipidemia) with ICT-based self-management and educational program can improve clinical outcomes and overall health status, including quality of life and health habits. In addition to the economic burden, people with chronic disease experience various psychosocial crises such as anxiety and depression, which causes the deterioration of overall quality of life and increases social burden. However, standard Chronic Care Model (CCM) have limitations in that they do not provide self-management strategies of the patient in detail. Therefore, to improve the effectiveness of the CCM model, it is required to propose a new approach to the utilization of IT-based self-management program that is currently being developed to increase accessibility and efficiency of health care service. Primary outcomes of this study are as follow: Improvement of clinical indicators in patients with hypertension, diabetes and hyperlipidemia. Participants in this study will respond a baseline questionnaire about health habits, health behavior patterns and quality of life, diet, exercise, etc. After that, participants will be allocated randomly into the intervention group and the control group. The intervention group will receive self-management and educational program with ICT (S Healthing) while the control group will receive basic educational material with same contents on the disease. S Healthing is based ICT- program and includes educational contents and self-management program based on Smart Management Strategy for Health (SMASH). The intervention group will conduct self-management for 3 months through smart phone application and web program. Participants will receive a questionnaire about the quality of life and health habits with the clinical examination 3 months after baseline survey was conducted. The result from two questionnaires (baseline, post-intervention) and clinical outcomes will be compiled and be compared with each other.

Interventions

BEHAVIORALICT programs

ICT programs that include health information learning by disease and self-management based on Smart Management Strategy for Health (SMASH).

A Take-home book about chronic disease are provided for self-education

Sponsors

National Evidence-Based Healthcare Collaborating Agency
CollaboratorOTHER_GOV
National Institute of Health, Korea
CollaboratorOTHER_GOV
National Clinical Research Coordination Center, Seoul, Korea
CollaboratorOTHER_GOV
Korea Health Industry Development Institute
CollaboratorOTHER_GOV
Seoul National University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Masking description

No masking

Intervention model description

Parallel Assignment

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subject 19 years old and more * Subject who understands the purpose of the study and signs with informed consent form * Subject with chronic disease (hypertension, diabetes, dyslipidemia) * Subject with more than one Poor Disease Control Indicator 1. HbA1C 7.0% or more 2. Systolic BP 140mmHg or more 3. LDL-cholesterol 130mg/dL or more * Subjects who use smart phones and PCs (those who can use ICT-based health care programs)

Exclusion criteria

* Inability to speak, understand, or write Korean * Inability to understand the contents of the provided materials due to poor eyesight and hearing * Medical conditions that would limit adherence to participation of the clinical trial (as confirmed by their referring physician; e.g. dyspnea, severe depression and other mental disorders)

Design outcomes

Primary

MeasureTime frameDescription
Success in clinical outcomes of Hypertension from baseline to 3 monthsBaseline, 3 months post-interventionChange in Systolic blood pressure(mmHg)
Success in clinical outcomes of Dyslipidemia from baseline to 3 monthsBaseline, 3 months post-interventionChange in LDL Cholesterol (mg/dL)
Success in clinical outcomes of primary disease Diabetes from baseline to 3 monthsBaseline, 3 months post-interventionChange in HbA1c (%)

Secondary

MeasureTime frameDescription
Quality of life (SF-12)Baseline, 3 months post-interventionImprovement of quality of life (SF-12)
Health behavior patternsBaseline, 3 months post-interventionWe identify health habits by dividing into five steps according to the TTM stage. We evaluate increase in maintenance rate of health behavior patterns.
Quality of life (Euro-QoL)Baseline, 3 months post-interventionImprovement of quality of life (Euro-QoL)
Quality of life (Mcgill QOL)Baseline, 3 months post-interventionImprovement of quality of life (Mcgill QOL)
DepressionBaseline, 3 months post-interventionChange in depression score (PHQ-9)
Health Management StrategiesBaseline, 3 months post-interventionWe use Smart Management Strategy for Health Assessment Tool (SAT) to assess their self-management (SM) strategies of health by themselves. We evaluate improvement of Health Management Strategies.

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 20, 2026